Intraocular bioactive agent delivery compositon including a molecular partitioning system

Details for Australian Patent Application No. 2010242939 (hide)

Owner Allergan, Inc.

Inventors Shi, Ruiwen; Hughes, Patrick M.

Agent Davies Collison Cave

Pub. Number AU-A-2010242939

PCT Pub. Number WO2010/127206

Priority 12/434,541 01.05.09 US

Filing date 30 April 2010

Wipo publication date 4 November 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/127206 Priority application(s): WO2010/127206

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010242943-Method of reducing intraocular pressure in humans

2010242938-Fixed dose drug combination formulations